|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2009-3-23
|
|
pubmed:abstractText |
Chylothorax is a relatively uncommon condition defined as an abnormal collection of lymphatic fluid within the pleural space. We are reporting the use of OK-432 for treatment of prolonged idiopathic congenital chylothorax in 2 newborn infants who failed to respond to conservative medical therapy, including octreotide injection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1531-5037
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
44
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
e37-9
|
|
pubmed:meshHeading |
pubmed-meshheading:19302843-Antineoplastic Agents,
pubmed-meshheading:19302843-C-Reactive Protein,
pubmed-meshheading:19302843-Chest Tubes,
pubmed-meshheading:19302843-Chylothorax,
pubmed-meshheading:19302843-Female,
pubmed-meshheading:19302843-Humans,
pubmed-meshheading:19302843-Infant, Newborn,
pubmed-meshheading:19302843-Instillation, Drug,
pubmed-meshheading:19302843-Male,
pubmed-meshheading:19302843-Octreotide,
pubmed-meshheading:19302843-Picibanil,
pubmed-meshheading:19302843-Pleural Effusion,
pubmed-meshheading:19302843-Respiration, Artificial,
pubmed-meshheading:19302843-Treatment Failure
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Treatment with OK-432 for persistent congenital chylothorax in newborn infants resistant to octreotide.
|
|
pubmed:affiliation |
The Department of Pediatrics, Nagara Medical Center, Gifu 502-8558, Japan.
|
|
pubmed:publicationType |
Journal Article
|
